The impact of clinical sample collection timing on FRα expression and mirvetuximab soravtansine patient outcomes in the MIRASOL (GOG 3045/ENGOT-ov55) trial

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Sabrina Chiara Cecere, Olivier Tredan, Eleonora Teplinsky, Ana Santaballa, Gordon C. Jayson, Alessandro D. Santin, Greet Huygh, Noelle Gillette Cloven, Jeong-Won Lee, Silvia Derio, Dagmara Klasa-Mazurkiewicz, Ingrid Boere
+7 more Shani Breuer, Ying Zhuo, Tetiana Piatnytska, Zhi Li, Emily Deutschman, Dominique Berton, Charles Anderson
DOI: 10.1016/j.ijgc.2025.102907
Cited by: 1

Fields of Study & Subjects

Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research Multiple Myeloma Research and Treatments

Publication details

Journal / source
International Journal of Gynecological Cancer
Publisher
Elsevier BV
Volume
36
Issue
2
Pages
102907–102907
Publication date
1 February 2026
Language
EN